Melanoma Network
  • Home
  • About Us
    • Background
    • Objectives
    • Structure and governance
      • Management Committee
      • Advisory Board
      • Subcommittees / working parties
      • Network Coordinating Unit
    • Work Plan 2007 - 2010
  • Services
    • Projects
      • Clinical practice guidelines
      • Dissemination of the guidelines
      • Implementation of the guidelines
      • Clinical protocols
      • Patterns of care
      • Audit of pathology reporting
      • Patient pathways
      • Patient support services & information
      • Recurrence of melanoma
      • Interactive website
      • Review of education programs
      • Benchmarking clinical practice
      • Melanoma Public Forum
      • Melanoma symposium & doctor forum
    • Resources & Links
      • Guidelines & Protocols
      • Network Publications & Reports
      • Quick Links
      • Educational Resources
      • Patient resources, referral pathways, support services
    • Forthcoming events
    • Latest online research & news
      • Research
      • News
    • Current clinical trials
      • MSLT II
      • M10 - 440
      • TEAM
      • Whole Brain Radiotherapy
      • Chemosensitivity
      • GSK DERMA
      • ECOG-1697
      • EORTC 18071
      • Topical immunotherapy
      • Definitions of Phases
    • Melanoma researchers
      • Funding bodies and research opportunities
      • Organizations involved in melanoma research
  • Members Area
  • Contact Us

  • Register of members
  • List of Founding Members
  • Benchmarking clinical practice Restricted
  • Educational videos for clinicians
  • Newsletter
  • Update on projects
  • Edit your details

Benchmarking clinical practice

This section is restricted to those who contribute to our data collection

 

Print this page


Melanoma Network
© Copyright 2009 Melanoma Network   |    Funded by NSW Health    |   Terms & Conditions   |   Site Map
Powered by SiteSuite